February 26, 2020 / 10:32 PM / a month ago

BRIEF-Portola Pharmaceuticals Posts Loss Per Share Of $1.24

Feb 26 (Reuters) - Portola Pharmaceuticals Inc:

* PORTOLA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 NON-GAAP LOSS PER SHARE $0.75

* Q4 REVENUE $29.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $29.2 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $-0.88 — REFINITIV IBES DATA

* Q4 LOSS PER SHARE $1.24

* PORTOLA PHARMACEUTICALS - CASH, CASH EQUIVALENTS AND INVESTMENTS AT DEC 31, 2019, TOTALED $466.2 MILLION, COMPARED WITH $317.0 MILLION AS OF DEC 31, 2018

* FOR FISCAL YEAR 2020, PORTOLA EXPECTS TOTAL RESEARCH AND DEVELOPMENT EXPENSES TO BE BETWEEN $105 MILLION AND $120 MILLION

* PORTOLA EXPECTS TOTAL SG&A EXPENSES TO BE BETWEEN $235 MILLION AND $250 MILLION IN 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below